1-10 of 10
Howard M. Stern
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predicting Clinical Response and Safety of JCAR017 in B-NHL Patients: Potential Importance of Tumor Microenvironment Biomarkers and CAR T-Cell Tumor Infiltration

Christina Swanson, PhD, Trevor Do, Samantha Merrigan, Shaparak Lonning, Kim Merriam, Joshua Prentiss, Janani Sridar, Claire L Sutherland, PhD, Benhuai Xie, PhD, Minh Pham, Daniel Li, PhD, Tina Albertson, MD, Howard M Stern, MDPhD, Sharon Moulis, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 194.
https://doi.org/10.1182/blood.V130.Suppl_1.194.194
Published: 2017
Journal Articles

a Phase 1 Evaluation of Duvelisib (IPI-145), a PI3K-δ,γ Inhibitor, in Patients with Relapsed/Refractory iNHL

Ian Flinn, Yasuhiro Oki, MD, Manish Patel, Steven M. Horwitz, MD, Francine M. Foss, MD, Jennifer Sweeney, Kerstin Allen, MA, Mark Douglas, MS, Lori Steelman, Joi Dunbar, PharmD, Howard M. Stern, MD PhD, Patrick Kelly, MD, Brad Kahl, MD
Journal: Blood
Blood (2014) 124 (21): 802.
https://doi.org/10.1182/blood.V124.21.802.802
Published: 2014
Journal Articles

Duvelisib (IPI-145), a Phosphoinositide-3-Kinase-δ,γ Inhibitor, Shows Activity in Patients with Relapsed/Refractory T-Cell Lymphoma

Steven M. Horwitz, MD, Pierluigi Porcu, MD, Ian Flinn, Brad S. Kahl, MD, Jennifer Sweeney, Howard M. Stern, MD PhD, Mark Douglas, MS, Kerstin Allen, MA, Patrick Kelly, MD, Francine M. Foss, MD
Journal: Blood
Blood (2014) 124 (21): 803.
https://doi.org/10.1182/blood.V124.21.803.803
Published: 2014
Journal Articles

Duvelisib (IPI-145) Inhibits Malignant B-Cell Proliferation and Disrupts Signaling from the Tumor Microenvironment through Mechanisms That Are Dependent on PI3K-δ and PI3K-γ

Marisa Peluso, MS, Kerrie Faia, MS, David Winkler, PhD, Nidhi Patel, MS, Erin Brophy, BS, Kerry White, BA, Mark Douglas, MS, Howard M. Stern, MD PhD, Vito Palombella, PhD, Karen McGovern, PhD, Jeffery L. Kutok, MD PhD
Journal: Blood
Blood (2014) 124 (21): 328.
https://doi.org/10.1182/blood.V124.21.328.328
Published: 2014
Journal Articles

Duvelisib (IPI-145), a PI3K-δ,γ Inhibitor, Is Clinically Active in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Susan O'Brien, Manish Patel, Brad S. Kahl, MD, Steven M. Horwitz, MD, Francine M. Foss, MD, Pierluigi Porcu, MD, Jennifer Sweeney, Kerstin Allen, MA, Kerrie Faia, MS, Howard M. Stern, MD PhD, Patrick Kelly, MD, Ian Flinn
Journal: Blood
Blood (2014) 124 (21): 3334.
https://doi.org/10.1182/blood.V124.21.3334.3334
Published: 2014
Journal Articles

Clinical Activity of Duvelisib (IPI-145), a Phosphoinositide-3-Kinase-δ,γ Inhibitor, in Patients Previously Treated with Ibrutinib

Pierluigi Porcu, MD, Ian Flinn, Brad S. Kahl, MD, Steven M. Horwitz, MD, Yasuhiro Oki, John C. Byrd, MD, Jennifer Sweeney, Kerstin Allen, MA, Kerrie Faia, MS, Min Ni, PhD, Howard M. Stern, MD PhD, Patrick Kelly, MD, Susan O'Brien
Journal: Blood
Blood (2014) 124 (21): 3335.
https://doi.org/10.1182/blood.V124.21.3335.3335
Published: 2014
Journal Articles

Treatment With The Potent PI3K-δ,γ Inhibitor IPI-145 Is Associated With Rapid Decreases In Specific Cytokines, Chemokines and Matrix Metalloproteinases In The Serum Of Patients With Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma

Mark Douglas, M.S., Ken Allison, M.S., Synder Ted, B.A., Kerstin Allen, MA, Brad S. Kahl, MD, Steven M. Horwitz, MD, Ian W. Flinn, MD, PhD, Patrick Kelly, MD, Howard M. Stern, M.D., Ph.D
Journal: Blood
Blood (2013) 122 (21): 1633.
https://doi.org/10.1182/blood.V122.21.1633.1633
Published: 2013
Journal Articles

The Potent PI3K-δ,γ Inhibitor IPI-145 Exhibits Differential Activity In Diffuse Large B-Cell Lymphoma (DLBCL) Cell Lines

Veronica Campbell, BS, Ryan Thompson, PhD, Vivian Villegas, MS, Jennifer Proctor, B.S., Karen McGovern, PhD, Jeffery L. Kutok, MD, PhD, Howard M. Stern, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1832.
https://doi.org/10.1182/blood.V122.21.1832.1832
Published: 2013
Journal Articles

Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia

Ian Flinn, MD, PhD, Manish Patel, MD, Brad S. Kahl, MD, Steven M. Horwitz, MD, Francine M. Foss, MD, Yasuhiro Oki, MD, Pierluigi Porcu, MD, Jennifer Sweeney, BS, Kerstin Allen, MA, Kerrie Faia, MS, Patricia Harris, MPH, Joi Dunbar, PharmD, Howard M. Stern, M.D., Ph.D., Patrick Kelly, MD, Susan O'Brien, MD
Journal: Blood
Blood (2013) 122 (21): 677.
https://doi.org/10.1182/blood.V122.21.677.677
Published: 2013
Journal Articles

Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation

David Traver, Alissa Winzeler, Howard M. Stern, Elizabeth A. Mayhall, David M. Langenau, Jeffrey L. Kutok, A. Thomas Look, Leonard I. Zon
Journal: Blood
Blood (2004) 104 (5): 1298–1305.
https://doi.org/10.1182/blood-2004-01-0100
Published: 2004
Includes: Multimedia, Supplemental data